Page last updated: 2024-09-03

ro 11-2933 and Breast Neoplasms

ro 11-2933 has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abderrabi, M; Marchal, S; Merlin, JL	1

Other Studies

1 other study(ies) available for ro 11-2933 and Breast Neoplasms

Article	Year
Comparative in vitro evaluation of dithiane analogs of tiapamil, Ro 11-2933, Ro 44-5911 and Ro 44-5912 as multidrug resistance modulators. Anti-cancer drugs, 1996, Volume: 7, Issue:4 Topics: Adenocarcinoma; Breast Neoplasms; Calcium Channel Blockers; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Leukemia, Experimental; Propylamines; Tumor Cells, Cultured; Verapamil	1996

Article

Year

Comparative in vitro evaluation of dithiane analogs of tiapamil, Ro 11-2933, Ro 44-5911 and Ro 44-5912 as multidrug resistance modulators.

Anti-cancer drugs, 1996, Volume: 7, Issue:4

Topics: Adenocarcinoma; Breast Neoplasms; Calcium Channel Blockers; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Leukemia, Experimental; Propylamines; Tumor Cells, Cultured; Verapamil

1996